News


Whole Genome Sequencing – Ahead of its Time?

At the Food Safety Summit in Rosemont, Illinois this past week there was a great deal of discussion about the use of Whole Genome Sequencing (WGS).  There were presentations from officials from CDC and FDA who discussed how WGS is being used in conjunction with the Pulse Net and GenomeTrakr databases and how this use of WGS has been essential at investigating foodborne illness outbreaks and tracing them back to their source.

Other presentations addressed technical issues related to the use of WGS. While everyone recognized that the technology is powerful and provides a significant increase in the detection and resolution of pathogens compared to other available technologies, caution was advised as the technology is not the panacea that some are starting to think that it is.  Success in using WGS comes from knowing exactly what the data is and is not able to tell you.  A point that was raised repeatedly was just because the genome sequence of a patient-derived pathogen matches that found in a food plant does not automatically mean that plant is the source.  The WGS data must be used in conjunction with data from a thorough epidemiological investigation.  CDC officials at the Summit indicated that while they considered WGS to be powerful evidence they concluded that epidemiological data is ultimately more reliable in source identification.

Something else noticeable was that the presentations on WGS at the Summit were delivered primarily by regulators, university researchers and public health officials – not food processors.  In our view, this is because this is where most of the work with WGS is occurring – not with food processors.

As part of our Food Safety Insights program in conjunction with Food Safety Magazine, we have conducted multiple surveys of food processors about their use of WGS over the past few years.  In the surveys that we’ve conducted each year since 2017, which include responses from nearly 500 food processors, no less than 90% of the respondents each year indicated that they have not yet employed WGS in any capacity.  Of those who indicated that they have used the technology, most said that they have not used the

technology on a routine basis but only on a periodic basis to identify the source of contamination as part of a specific project – such as “search and destroy” projects designed to identify and eliminate “hot spots.”   One processor reported that they used WGS as part of a one-time project to compare the pathogens found in environmental samples across multiple facilities to determine if they had a common source.  A few reported that they had used WGS, but the data did not help them solve their issue, and they felt WGS was less useful than they originally hoped when they started the project.

As of now, WGS seems to remain a technology of limited applicability for food processors.  Some experts believe it will remain this way for years to come.  The ones we’ve spoken with believe the use of WGS by processors for incident investigations will continue to grow but question whether it will ever see widespread use for analysis of daily or routine samples.

This is a market that we will continue to track closely.

What Industry and FDA are thinking about FSMA Implementation

The past two years have been a challenge for both food processors and the FDA in understanding and implementing FSMA.  In the June/July 2017 issue of Food Safety Magazine, at the start of FSMA compliance for most processors, we asked processors in the US, Canada and around the world about their plans for FSMA compliance, how they saw the regulations changing their operations, how they were preparing for FDA inspections, and anything else that they saw that they would be facing.

Now that it’s 2019 and processors have had (up to) 2 years of experience with FSMA, we wanted to get an update on how they were dealing with the new rules, what changes they’ve made, what’s working and what’s not, and what they’ve learned about this new regulatory environment.  Our findings have been published in the April/May 2019 issue of Food Safety Magazine – in the Food Safety Insights column.

https://www.foodsafetymagazine.com/magazine-archive1/aprilmay-2019/what-industry-and-fda-are-thinking-about-fsma-implementation-part-1/

We found out that many processors have been dealing with the changes with the changes relatively well, considering the scope of the impacts.  While many of their concerns still revolve around some of the same issues – interpretation of the regulations and managing conflicts from different requirements – their concerns and fears about onerous FDA inspections seems to have seems to have faded.  In 2017, 60% of US/Canadian processors disagreed that the FDA will “educate before they regulate” and they expressed concern that FDA FSMA inspections would be difficult.  In our current survey, 72% said that they found that indeed the FDA is educating before they regulate – and impressive turnaround in only two years!  (Which has been recognized by FDA Officials – https://twitter.com/FrankYiannasFDA/status/1118989658573234176 

Many of the processors who have had an inspection have said the inspections have been going very well, the FDA inspectors are better trained and more open to listening to the processors, and some processors also said their most recent inspections have been the “best ever.”  It seems that we have found out that something is going quite well with FSMA inspections.

In Part Two of this investigation, which will be published in the June/July issue of Food Safety Magazine, we will present  more findings about the changes in sampling, testing and environmental monitoring that processors have been making for FSMAS compliance and we will also hear directly from the FDA on their response to the survey findings.

Outsourcing: Pathogen Testing under the Microscope

The December – January edition of Food Safety Insights is now available in Food Safety Magazine. In this month’s column, we examine the changing food pathogen testing market. We look at the food pathogen testing practices of 100 food processors in the US, Canada and Mexico.

As we have reported in previous articles and posts, food processors are increasingly deciding that they are not in the food testing business and it is to their benefit to outsource their testing. Only the largest food processors are keeping their in-house labs and rest are sending samples to commercial labs – leaving the market divided between consolidating large food processor in-house labs and large commercial labs. This will have a dramatic impact on the markets for diagnostic products.

The New Face of Sanitation Programs: New Rules, New Challenges

The October – November edition of Food Safety Insights is now available in Food Safety MagazineIn this version, we look at the Sanitation Programs of food processors, how they are changing under FSMA, what tools – new and traditional – are being used and how processors are reacting to the new FSMA FDA inspections.

Food Safety Insights is a cooperative program between the industry experts at Food Safety Magazine and the food safety market experts at Strategic Consulting to bring you the latest market research, insights and trends in food safety, analytical testing, diagnostics, laboratory services, sanitation and related topics in quality and safety testing and assurance in the food and beverage industry.

In each edition of Food Safety Magazine, the Food Safety Insights column will review a market topic in food safety.  Our insights come from primary research conducted each month with food processors and laboratories throughout the United States and around the world and provide you with up-to-date facts and figures not available anywhere else. This unique program will advance your understanding of food safety markets and where the best opportunities are developing.

Strategic Consulting Expands to Meet Needs of Industrial Diagnostics Market

Strategic Consulting, Inc., has added Robert J. Ferguson as Managing Director as it continues to expand to meet the growing demand for market intelligence and business strategy in the industrial diagnostics market.

Strategic Consulting, Inc. (SCI), the leading knowledge resource for business strategy and market intelligence in the industrial diagnostics industry, announced in advance of the International Association for Food Protection (IAFP) Annual Meeting that Robert J. Ferguson has joined the company as Managing Director. Founded in 1996 by President, Tom Weschler, Strategic Consulting focuses on microbiology-based, quality and safety testing in the food, beverage, pharmaceutical, and personal care product industries, and in environmental and industrial process water.

“In our 20-year history, we’ve seen tremendous growth and change in the industrial diagnostics industry, particularly in the food safety sector,” Mr. Weschler said. “With Bob Ferguson’s expertise in all aspects of the market, plus extensive experience in business management, strategy development and international business, SCI will be expanding its services and offering our clients an even deeper skill set and knowledge base.”

Market research is vital to the development of the industrial market, and continues to be in demand. In 2017, we anticipate delivery of new editions of our report on Microbiology Testing in the Global Food Industry as well as the Food Contract Lab Report.

With more than 30 years in industrial and environmental diagnostics and laboratory businesses, Mr. Ferguson has expertise in accelerating growth, international business development, business turnarounds, M&A, and new product development in businesses ranging from start-ups to Fortune 500 corporations. Prior to joining SCI, Mr. Ferguson was Worldwide Vice President and General Manager for Becton Dickinson’s (BD) Industrial Microbiology and Clinical Media Business Unit; a $350M global business serving the clinical and industrial diagnostic markets in food safety, pharmaceutical, personal care and medical devices, with customers in more than 100 countries around the world.

Ferguson, Managing Director, Strategic Consulting, SCI

Robert J. Ferguson, Managing Director

“Having worked with Tom and Strategic Consulting for many years, I am well aware of SCI’s reputation as the leading market knowledge and strategy resource for industrial diagnostics, “Ferguson said. “I’m pleased to be joining SCI, and I look forward to contributing to and building on its outstanding work.”

In its 20-year history, SCI has built a reputation as the “go to” source in the industrial diagnostics space, in part through its 19 well-researched market reports, which are widely accepted by leading diagnostic manufacturers and investors as highly credible analyses of the industry. “SCI market reports having been developed through literally thousands of interviews with production companies worldwide in the food, pharmaceuticals and personal care industries,” Mr. Weschler said.

“Market research is vital to the development of the industrial market, and continues to be in demand,” Ferguson said. “In 2017, we anticipate delivery of new editions of our report on Microbiology Testing in the Global Food Industry as well as the Food Contract Lab Report.”

IMMR—4 is currently available online at www.strategic-consult.com, and a new edition of “Global Review of Microbiology Testing in the Industrial Market”(IMMR-5) will follow Food Micro—9 and FCLR—2, Mr. Ferguson said. SCI also will be expanding its capabilities to provide market research projects specific to individual client requirements.

###

Strategic Consulting, Inc. (SCI) provides market reports and business consulting on microbiology-based quality and safety testing for food, beverages, pharmaceuticals, personal care products, environmental water and industrial-process water. With more than 100 combined years of international management in the food safety testing and industrial diagnostics marketplaces, SCI’s principals have proven success in working with venture capital backed start-ups, publicly traded companies, technology acquisitions, and transformation of underachieving companies. For more information on Strategic Consulting and its current market reports, visit www.strategic-consult.com or call +1 443 244 5245.

For example you can buy medications that fights bacterial infections. These medicaments will not treat several infection such as the common cold. Some pharmacies offer to their consumers Viagra. Possibly you know about price of viagra or viagra price. Medicines, like Viagra, sure, is going to change your life. Also known as impotence is defined as the failure to maintain an erection suitable for intercourse. Currently for men of any age, it can be an early warning symptom for earnest illnesses, so it’s essential for your overall health, not just your sexual relationship, to see a sex therapist if you experience erection disfunction. Why it happen? What kinds of professionals treat sexual soundness problems in men?

Tagged , , ,

Faster, Better, Cheaper… What’s Most Important in a Pathogen Test?

SCI interviewed major food companies and food contract labs to determine what’s most important when choosing a pathogen test method.

For close to 20 years, Strategic Consulting (SCI) has been following the industrial microbiology market, and food safety testing applications in particular. As part of the data gathering for our most recent report, Industrial Microbiology Market Review, SCI interviewed 15 senior managers at major food companies and food contract labs (FCLs) to understand their priorities when choosing a pathogen diagnostic method. The interviews were roughly split between food companies and food contract labs.

SCI identified ten important attributes for evaluating a diagnostic method or instrument, and asked the interviewees to stack rank the top five items most important to them.

pathogen test, diagnostic methodThe three top-ranked choices were the same at both food companies and FCLs, with sensitivity/specificity the most important attribute. Second in importance was the ability of the method to be utilized in a broad range of food matrices. Ranking third was the cost-per-test for diagnostic reagents.

For food companies, time-to-results (TTR) was tied for third in the stack ranking, followed by ease-of-use (EOU)/automation in fifth place. Clearly food companies want quick results but only after they are assured that the pathogen diagnostic they are using provides accurate results and is able to work with a range of food types.

For food contract labs, the cost of the pathogen diagnostic instrument ranks fourth, and TTR is tied with the cost of labor per test for fifth. For FCLs, most of the key attributes in method selection are based on operational considerations, which makes perfect sense given testing is their business.

For example you can buy medications that fights bacterial infections. These medicaments will not treat several contagion such as the common cold. Some pharmacies offer to their consumers Viagra. Possibly you know about price of viagra or viagra price. Medicines, like Viagra, sure, is going to change your life. Also known as impotence is defined as the failure to maintain an erection suitable for intercourse. Currently for men of any age, it can be an early warning symptom for earnest illnesses, so it’s essential for your overall health, not just your sexual relationship, to see a sex therapist if you experience erection dysfunction. Why it happen? What kinds of professionals treat sexual heartiness problems in men?

Tagged , , , , , , , ,

Where Has the Growth in Food Safety Testing Gone?

Recent earnings reports from large industrial diagnostic companies in the food safety sector indicate a slowing of growth in this typically robust market. What’s going on? Has growth in the food safety testing market peaked, paused with the economic downturn, or just moved elsewhere?

Strategic Consulting (SCI) has just released our 19th market research report on the industrial microbiology market. Industrial Microbiology Market Review: Global Review of Microbiology Testing in the Industrial Market (IMMR-4) examines the industrial diagnostics market, which includes the food, beverage, pharmaceutical, personal care products, environmental water and industrial process sectors. You can read more about IMMR-4 here.

In addition to a detailed analysis by test volume, market value, organisms tested and methods used, IMMR-4 also provides a thorough discussion of market trends, drivers, and regulatory and topical issues specific to each sector. IMMR-4 also includes a business review of competition, consolidation and key success factors, and profiles 20 leading test manufacturers serving the industrial diagnostics market.

Extensive Primary Research in the Industrial Market

industrial market, primary research, strategic consultingIMMR-4 is based on extensive primary research into all aspects of the industrial microbiology market, including detailed interviews with producers, regulators and diagnostics competitors. SCI conducted more than 650 interviews in 23 countries around the world, with close to one-third of those interviews conducted in Asia (China, India, Indonesia, Thailand, Singapore and Vietnam) due to the region’s economic importance, in both production and consumption, in the industrial market sectors.

Interview data and other information were analyzed using a combined bottom-up and top-down approach. For example, overall market estimates were derived from the test volume numbers given by production companies, and then triangulated with other information gathered through SCI interviews and pubic information research.

In hundreds of interviews over the last two years, when QA/QC managers in production plants were asked about test volume growth, the general response was “yes, growth”. The drivers for test volume growth, such as new regulations and ongoing customer demand, are not consistent across all geographies however. North American and Asian/ROW plants report growth in test volumes, while test volume in European facilities remain flat. Although somewhat diminished, growth in micro test volumes continues even in the face of world economic issues.

In fact, the total market for industrial microbiology tests is projected to increase 25.7% over the next five years, from 2.0 billion tests in 2014 to 2.5 billion tests in 2019. This represents a 4.7% compound annual growth rate (CAGR) in test volumes, which is slower than over the past 20 years. In other words, testing is increasing but not as robustly. With many production companies implementing process improvements over the last decade, growth in test volume may be tied to increased consumption alone going forward.

What’s Up with Recent Financial Reports from Diagnostics Companies?

Given the test volumes and projected growth reported by food production companies, I was a bit surprised by the financial reports of some key companies in the food safety testing market. Roka Bioscience had no new sales of its Atlas System last quarter. Neogen reported that their food safety business grew only marginally (3%) for the current quarter. And although we can’t isolate the food safety business of industry giant bioMérieux, overall their industrial business was flat for the first nine months of the year.

With leading businesses showing little or no growth in the sizeable food safety testing market, are we seeing a market that has become overcrowded, with little or no growth remaining? Based on financial reports, it’s hard to know specifically where growth remains and where things are flat or declining, as these large companies do not report on a geographic or product basis.

Is it time to recalibrate expectations for the traditionally robust food safety testing market? Has the food safety diagnostics business reached its peak in spite of major drivers such as continued media coverage of foodborne outbreaks, ongoing implementation of FSMA, industry-wide efforts such as the Global Food Safety Initiative (GFSI), and the increased consumption of food that is sourced from all over the world?

Perhaps it’s time to recalibrate expectations for the traditionally robust food safety testing market.

I’m going to venture an uncharacteristic answer and say “perhaps”. Perhaps the increased focus on industry testing over the last ten years means that for the most part, major food producers have their testing programs (and thus volumes) in place. Perhaps the five-year economic malaise that has impacted so many countries and businesses is now affecting the until now unmatched growth engine of food safety diagnostics? Or perhaps it is all of the above.

Food Contract Labs Taking Market Share

One other possibility comes out of SCI’s recent review of a particular segment of the market, contract test labs. Over the past few years, there has been a shift in where analysis is performed with some sectors sending a greater percentage of samples outside to corporate facilities or contract testing labs. The Food Sector, driven by lab accreditation requirements among other factors, is utilizing contract labs more heavily in certain geographies.

Is competition for diagnostic manufacturers coming from businesses that had previously been among their best customers? Eurofins reported 15% growth in revenues for the first nine months of 2014. As food contract labs grow their market share in food safety testing, they are able to increase their influence over the test methods and products in use, and their purchase patterns can be different from food plant labs.

Stay tuned. As 2015 approaches, we’ll continue to watch, report and comment, here and on Linked In and Twitter.

And in the meantime, let us know what you think. Are the days of double-digit growth in food safety testing a thing of the past?

 

For example you can buy medications that fights bacterial infections. These medicaments will not treat several contagion such as the common cold. Some pharmacies offer to their consumers Viagra. Possibly you know about price of viagra or viagra price. Medicines, like Viagra, sure, is going to change your life. Also known as impotency is defined as the failure to maintain an erection suitable for intercourse. Currently for men of any age, it can be an early warning symptom for earnest illnesses, so it’s essential for your overall soundness, not just your sexual relationship, to see a sex therapist if you experience hard-on dysfunction. Why it happen? What kinds of professionals treat sexual health problems in men?

Tagged , , , , ,

Insight into the $6.5 Billion Global Industrial Microbiology Market

New research from Strategic Consulting, Inc. details microbiology testing conducted by companies around the world to ensure the quality and safety of products in the food, beverage, pharmaceutical and personal care markets, and in environmental water and industrial processes.

Strategic Consulting, Inc., the leading information resource for industrial diagnostics companies, has published a comprehensive new market report on microbiology testing in the global industrial market. Industrial Microbiology Market Review, Fourth Edition: Global Review of Microbiology Testing in the Industrial Market” (IMMR—4) tracks and compares past, current and future (projected) microbiology test volumes, market values and test methods for six sectors of the industrial market (Food, Beverage, Pharmaceutical, Personal Care Products, Environmental Water and Industrial Processes) in North America, Europe, Asia and the rest of the world (ROW).

industrial microbiology, market research, safety, quality

The industrial microbiology market is large and growing, the second largest diagnostics market after clinical diagnostics in test volume and market value. More than 90,000 industrial plants worldwide conduct close to 2 billion tests each year, which represents a market value of $6.5 billion. Because the demand for consumer products is growing as the world’s population grows, increases in product quality and safety testing appear to continue undaunted by current worldwide economic problems.

The global industrial market is complex, however, with varying testing requirements and regulations resulting in variations in growth across market sectors and geographies. According to Tom Weschler, president of Strategic Consulting, the rate of growth in the broader market is slowing when compared to previous years. “Numerous drivers for industrial testing, such as public and regulatory concern about product safety, continue to offer pockets of opportunity, but not in all areas. One example is rapid microbiology methods, which have seen significant adoption in certain sectors and geographies, and little or no uptake in others,” Weschler said.

Numerous drivers for industrial testing, such as public and regulatory concern about product safety, continue to offer pockets of opportunity, but not in all areas.

Industrial Microbiology Market Review (IMMR-4) provides detailed analysis and insights into the complexities of this market, including:

  • Past, current and projected test volumes and market values, with breakdowns by market sector, geographic regions, test methods and organisms tested.
  • In-depth views of the six market sectors, including market trends and drivers within each sector.
  • Test methods and technologies, from “traditional” to newer, rapid methods such as immunoassay and molecular methods.
  • Organisms of interest in “routine” microbiology testing including TVO, Coliform/E. coli and Yeast/Mold, as well as testing for specific pathogens.
  • Detailed business reviews, including profiles of 20 leading diagnostic companies such as bioMérieux, Neogen and Merck Millipore.

For many diagnostic companies, industrial microbiology is one piece of a larger diagnostics portfolio. As a result, market metrics can be difficult to ascertain. IMMR-4 fills this gap, and provides more than 200 pages of detailed discussion and 150 charts and diagrams. Importantly, these data and insights are based on extensive primary research into all aspects of the industrial microbiology market, including:

  • Detailed interviews with 650 production plants conducted in 23 countries in North America, Europe and Asia/ROW
  • 200 interviews in six countries of Asia (China, India, Vietnam, Indonesia, Singapore and Thailand)
  • Discussions with key opinion leaders, regulators and senior management at contract testing labs and diagnostic companies.

IMMR-4 offers five additional appendices with further detail on Organisms and Methods, the Food, Pharmaceutical and Personal Care Product sectors, and a completely new Review of Microbial Identification practices and technologies in the industrial market.

For more information about Industrial Microbiology Market Review, Fourth Edition: Global Review of Microbiology Testing in the Industrial Market(IMMR—4) download a prospectus or contact Strategic Consulting.

For example you can buy medications that fights bacterial infections. These medicaments will not treat several infection such as the common cold. Some pharmacies offer to their consumers Viagra. Possibly you know about price of viagra or viagra price. Medicines, like Viagra, sure, is going to change your life. Also known as impotence is defined as the failure to maintain an erection suitable for intercourse. Currently for men of any age, it can be an early warning symptom for earnest illnesses, so it’s essential for your overall soundness, not just your sexual relationship, to see a sex therapist if you experience erection disfunction. Why it happen? What kinds of professionals treat sexual soundness problems in men?

Tagged , , ,

High False Negative Rates For Pathogen Food Safety Testing

Even in best case scenarios, food safety testing labs are still averaging greater than 6% FALSE NEGATIVES on pathogen testing. Is this acceptable?

Continuing on the theme of pathogen diagnostics and observations from the recent IAFP meeting in Indianapolis, this blog looks at proficiency testing (PT) for pathogen analysis, and the recent finding by the the American Proficiency Institute (API) of a 6.6% false-negative rate on food safety PT samples (14-year average for the 1999-2012 period).

While at IAFP I met with Heather Jordan, who directs food PT programs at the American Proficiency Institute. API proficiency testing programs are used at many food labs in conjunction with lab accreditation programs. Proficiency testing is done at food plant labs (FPLs) and corporate labs, as well as at food contract testing labs (FCLs) as a way to demonstrate quality results in their food micro and chemistry testing.

More Proficiency Tests But Less Proficiency?

In fact, the use of PTs is increasing in food labs, which is probably tied in part to the push for lab accreditation by FSMA and non-government groups like GFSI.

Yet it seems to me that the current use of PTs doesn’t go far enough to enable an FPL or FCL to demonstrate overall laboratory competency, and gain or maintain accreditation (ISO 17025).

In most labs, PTs are done just a few times a year. And really, they test the competency of the lab technician and protocols used in analyzing the PT samples. They are not a holistic measure of the lab and its ability to consistently generate quality results on every test run by every operator in the lab.

In a previous life I ran a group of environmental testing labs, which also are required to run PT samples during the year. From this experience, I know that lab personnel are aware that PTs are in-house: The sample-receiving group logs them in, and then alerts management. As a result, the best operators usually are assigned to run the PTs. This kid-glove treatment is not representative of day-to-day practices and processes. If we really want to validate and accredit the proficiency of an entire lab, shouldn’t every operator be tested on all protocols in use?

Plus, if labs know when they are running PT samples, and likely have their best operators running them, shouldn’t there be few, if any, false-negative or false-positive results?

Surprisingly, that’s not what the API research found…

API Study: “Performance Accuracy for Food Pathogens Remains Problematic”

In a retrospective study, “Pathogen Detection in Food Microbiology Laboratories: An Analysis of Proficiency Test Performance,” API analyzed the results from 39,500 food proficiency tests conducted between 1999 and 2012 to see how U.S. labs are doing in detecting or ruling out contamination of four common food pathogens.

Over the 14-year period, “False negative results ranged from 3.3% to 14.0% for E. coli O157:H7; 1.9% to 10.6% for Salmonella spp; 3.4% to 11.0% for L. monocytogenes; and 0% to 19.8% for Campylobacter spp.” Most concerning is that while both false positive and false negative rates were down in the last year of the study, the cumulative false negative rate for the 14-year period was 6.6%.

As we know, false positive results (in which a sample that does not contain pathogens is incorrectly shown as positive) are a nuisance. But false negative test results—which fail to detect true pathogenic organisms in the sample—are not unacceptable.

API, false negative, proficiency test, pathogen

The cumulative average false positive rate was 3.1%, less than half of the false negative rate for the same period.

The objective of the study—and, I would think, of proficiency testing in general—is to demonstrate improvement in lab performance year over year. The results of the API report concluded to the contrary, however: “Performance accuracy for food pathogens remains problematic with the recent cumulative trend showing a slight decrease for false positive and false negative results.”

Performance accuracy for food pathogens remains problematic with the recent cumulative trend showing a slight decrease for false positive and false negative results.

Clearly if false negatives happen in proficiency programs, they happen in the course of regular testing at food labs. I’m told that many FCLs and FPLs rely on other parts of their QA systems to make sure testing is being conducted properly. Even so, the documentation of ongoing and unacceptably high false negative rates in PT testing is a big concern for everyone.

It also points to a number of follow-on questions:

  • Would the false negative and false positive results be even higher if every technician, rather than the best operator, performed the analysis?
  • PT samples are created in only a couple of sample matrices. Would results be even worse if performed on the myriad of sample matrices present in the food industry?
  • What are the performance results among all of the pathogen methods available? Are some methods better than others when measured in real world conditions? Do the more complex protocols of some pathogen diagnostic systems result in poorer PT performance results?
  • Would PT results and, even more important, lab proficiency improve if the frequency of PTs increased, and were required of every technician involved with real food samples?
  • How can proficiency testing be used to isolate problem areas, whether in the pathogen diagnostic method or the competency of lab operators and processes?
  • Is the performance data different between food contract labs and food plant labs? And are all FCLs are equal, or are some more able to deliver quality results?

 

For example you can buy medications that fights bacterial infections. These medicaments will not treat several infection such as the common cold. Some pharmacies offer to their consumers Viagra. Possibly you know about price of viagra or viagra price. Medicines, like Viagra, sure, is going to change your life. Also known as impotence is defined as the failure to maintain an erection suitable for intercourse. Currently for men of any age, it can be an early warning symptom for earnest illnesses, so it’s essential for your overall health, not just your sexual relationship, to see a sex therapist if you experience erection disfunction. Why it happen? What kinds of professionals treat sexual soundness problems in men?

Tagged , , , , ,

2 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide

New market research from Strategic Consulting, Inc. reports on the industrial microbiology testing conducted by companies worldwide to ensure safe and wholesome products that meet label claims.

Industrial Microbiology Market Review, Fourth Editionis based on primary research with more than 650 production facilities in 23 countries in North America, Europe and Asia, including China and India.

Woodstock, Vt. — A new market research report detailing industrial microbiology testing around the world is available from Strategic Consulting, Inc., the leading information resource for industrial diagnostics companies. Industrial Microbiology Market Review, Fourth Edition: Global Review of Microbiology Testing in the Industrial Market (IMMR—4) tracks and compares microbiology test volumes, market values and methods used in in North America, Europe and Asia, and forecasts future volumes and market values through to 2019.

According to IMMR—4, industrial microbiology test volume will reach 2 billion tests in 2014, an increase of 500 million tests per year since last surveyed in 2008.

IMMR—4 is based on primary research with the quality assurance managers of production facilities in the food, beverage, pharmaceutical, personal care products / cosmetics (including nutraceuticals), environmental water, and industrial processes sectors. Strategic Consulting conducted more than 650 detailed interviews in 23 countries around the world. Close to one-third of the interviews were conducted in six countries of Asia (China, India, Indonesia, Thailand, Singapore and Vietnam) due to the region’s economic importance, in both production and consumption, in the industrial market sectors.

Close to 1/3 of the interviews were conducted in Asia due to the region’s economic importance in the industrial market sectors.

IMMR—4 details testing practices and methods used by geographic regions (North America, Europe and Asia/ROW-Rest of the World) for each business sector. Differences in the test method used, the organisms tested, and the frequency of testing is reviewed.

Rapid Micro Methods Taking Market Share

industrial microbiology, test volume, IMMR-4, rapid micro methods

According to Tom Weschler, president of Strategic Consulting and lead author of IMMR—4, newer, rapid microbiological methods (RMMs) are growing and taking market share in the industrial market. “Rapid micro methods will account for more than 50% of test volume growth in 2014,” Weschler said. Adoption of RMMs varies by business sector and geographic region, however, in some cases significantly, Weschler added. For example, in China use of rapid micro methods in the food sector is minimal, while the use of RMMs in the personal care products and pharmaceutical sectors is more prevalent.

Industrial Microbiology Market Review, Fourth Edition includes a thorough review of the pharmaceutical and personal care product sectors, and new coverage of microbiology testing in the fast growing nutraceuticals market.

Rapid micro methods will account for more than 50% of test volume growth in 2014.

IMMR—4 offers a detailed business review of the leading diagnostic companies serving the industrial market, including revenues, sectors covered and products/technologies offered. “While there are no dominant competitors that cross all business sectors, leading companies are emerging in certain areas,” Weschler said. In addition, IMMR—4 profiles 20 competitors in the industrial market including bioMerieux, Merck Millipore, DuPont, 3M, Bio-Rad and Neogen.

IMMR—4 is based on detailed interviews conducted by Strategic Consulting and integrated into its database of industrial microbiology diagnostics trends and practices, which has been published in 19 market research reports over the last 18 years. Delivering both extensive new data and a detailed historical perspective, Strategic Consulting market research reports are widely accepted by leading diagnostic manufacturers and investors as highly credible analyses of the industry.

For more information about Industrial Microbiology Market Review, Fourth Edition: Global Review of Microbiology Testing in the Industrial Market(IMMR—4), contact Strategic Consulting.

For example you can buy medications that fights bacterial infections. These medicaments will not treat several contagion such as the common cold. Some pharmacies offer to their consumers Viagra. Possibly you know about price of viagra or viagra price. Medicines, like Viagra, sure, is going to change your life. Also known as impotence is defined as the failure to maintain an hard-on suitable for intercourse. Currently for men of any age, it can be an early warning symptom for earnest illnesses, so it’s essential for your overall health, not just your sexual relationship, to see a sex therapist if you experience erection disfunction. Why it happen? What kinds of professionals treat sexual health problems in men?

Tagged , ,